Provides the 2013 European Society of Cardiology recommendations for the management of stable coronary artery disease.
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“Before there is any discussion about revascularization, patients should receive optimal medical therapy. The decision on the type of revascularization should then be based on a discussion between the surgeon and the cardiologist in the heart team. Moreover, revascularization should only be considered in patients with evidence”
“Another new aspect is that the diagnostic algorithm is based on pre-test probability, in line with the 2010 UK National Institute for Health and Clinical Excellence (NICE) guidelines on chest pain of recent onset. The estimation of pre-test probability is based on the latest data measuring the prevalence of coronary artery stenosis in a current large cohort of male and female patients of various ages with various clinical presentations.”
“It is in fact the ECG itself with its suboptimal test properties which induced us to limit the role of the ECG in the current guidelines. Nevertheless, the ECG is still a good technique as long as the pretest probability of patients with suspected stable CAD is below 65%. The low sensitivity of about 50% of the exercise stress ECG makes testing at higher pretest probabilities, however, not useful.”
Emphasizes individualized judgement in stable CAD management; leaves open the prognostic impact of guideline adherence in current practice.
The ESC Guidelines represent the views of the ESC and were arrived at after careful consideration of the available evidence at the time they were written. Health professionals encouraged to take them fully into account when exercising their clinical judgement. The Guidelines do not, however, override the individual responsibility of health professionals make appropriate decisions in the circumstances of the individual patients, in consultation with that patient and where appropriate and necessary the patient’s guardian or carer. It also the health professional’s responsibility to verify the rules and regulations applicable to drugs and devices at the time of prescription.
No takes yet. Share an insight, caveat, or question.
Montalescot et al. (2013) conducted a review in stable coronary artery disease. ESC Guidelines was evaluated. The 2013 ESC Guidelines provide recommendations for the management of stable coronary artery disease based on available evidence, emphasizing the role of individual clinical judgement.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: